Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Asthma COPD Drugs Companies

Asthma and Chronic Obstructive Pulmonary Disease (COPD) are chronic respiratory conditions, and several pharmaceutical companies are actively involved in the research, development, and manufacturing of drugs to manage and treat these conditions.

Asthma and COPD Drugs Key Companies

Latest Asthma and COPD Drugs Companies Update:

GlaxoSmithKline (GSK) Presented positive Phase 3 data for their investigational IL-5 inhibitor, BEZP1144, demonstrating significant improvements in lung function and reduction in exacerbations for severe asthma patients.

AstraZeneca Received FDA approval for the first generic version of Symbicort, opening up cost-effective treatment options for patients.

Viatris and Kindeva Drug Delivery Launched Breyna, a budesonide-formoterol combination inhaler for asthma and COPD, targeting patients above six years old.

Novartis Announced expansion of clinical trials for their IL-17/IL-17A inhibitor, QGE003, to include patients with moderate-to-severe COPD.

Roche Collaborated with Lung Foundation Australia to develop and implement a digital platform for self-management of chronic respiratory diseases like asthma and COPD.

List of Asthma and COPD Drugs Key companies in the market

Teva Pharmaceutical Industries Ltd (Israel)

GSK plc (UK)

Merck& Co., Inc (US)

Hoffmann-La Roche Ltd (Switzerland)

AstraZeneca (UK)

Boehringer Ingelheim International GmbH (Germany)

Sanofi (France)

Koninklijke Philips N.V. (Netherlands)

BD (US)

Sunovion Pharmaceuticals, Inc (US)

Asthma COPD Drugs Market Highlights:

Asthma COPD Drugs Market Size

Asthma COPD Drugs Market Trends

Asthma COPD Drugs Market Analysis

Asthma COPD Drugs Market Share

Asthma COPD Drugs Market Highlights:

Asthma COPD Drugs Market Trends

Asthma COPD Drugs Market Analysis

Asthma COPD Drugs Market Share

Asthma COPD Drugs Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.